the paul bevan cancer foundation
the paul bevan cancer foundation Company Information
Company Number
02807079
Next Accounts
Dec 2025
Shareholders
-
Group Structure
View All
Industry
Other human health activities
Registered Address
thames hospice windsor road, maidenhead, SL6 2DN
Website
http://thameshospice.org.ukthe paul bevan cancer foundation Estimated Valuation
Pomanda estimates the enterprise value of THE PAUL BEVAN CANCER FOUNDATION at £0 based on a Turnover of £0 and 0.53x industry multiple (adjusted for size and gross margin).
the paul bevan cancer foundation Estimated Valuation
Pomanda estimates the enterprise value of THE PAUL BEVAN CANCER FOUNDATION at £0 based on an EBITDA of £0 and a 4.1x industry multiple (adjusted for size and gross margin).
the paul bevan cancer foundation Estimated Valuation
Pomanda estimates the enterprise value of THE PAUL BEVAN CANCER FOUNDATION at £0 based on Net Assets of £0 and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
The Paul Bevan Cancer Foundation Overview
The Paul Bevan Cancer Foundation is a live company located in maidenhead, SL6 2DN with a Companies House number of 02807079. It operates in the other human health activities sector, SIC Code 86900. Founded in April 1993, it's largest shareholder is unknown. The Paul Bevan Cancer Foundation is a mature, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
The Paul Bevan Cancer Foundation Health Check
There is insufficient data available to calculate a health check for The Paul Bevan Cancer Foundation. Company Health Check FAQs
0 Strong
0 Regular
0 Weak
Size
There is insufficient data available for this Key Performance Indicator!
- - The Paul Bevan Cancer Foundation
- - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Production
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Profitability
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Employees
There is insufficient data available for this Key Performance Indicator!
- - The Paul Bevan Cancer Foundation
- - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Efficiency
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- The Paul Bevan Cancer Foundation
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - The Paul Bevan Cancer Foundation
- - Industry AVG
Debt Level
There is insufficient data available for this Key Performance Indicator!
- - The Paul Bevan Cancer Foundation
- - Industry AVG
THE PAUL BEVAN CANCER FOUNDATION financials
The Paul Bevan Cancer Foundation's latest turnover from March 2024 is estimated at 0 and the company has net assets of 0. According to their latest financial statements, we estimate that The Paul Bevan Cancer Foundation has no employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 2,000 | ||||||||||||||
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | |||||||||||||||
| Interest Receivable | |||||||||||||||
| Pre-Tax Profit | |||||||||||||||
| Tax | |||||||||||||||
| Profit After Tax | |||||||||||||||
| Dividends Paid | |||||||||||||||
| Retained Profit | |||||||||||||||
| Employee Costs | |||||||||||||||
| Number Of Employees | |||||||||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | |||||||||||||||
| Intangible Assets | |||||||||||||||
| Investments & Other | |||||||||||||||
| Debtors (Due After 1 year) | |||||||||||||||
| Total Fixed Assets | |||||||||||||||
| Stock & work in progress | |||||||||||||||
| Trade Debtors | |||||||||||||||
| Group Debtors | |||||||||||||||
| Misc Debtors | |||||||||||||||
| Cash | |||||||||||||||
| misc current assets | |||||||||||||||
| total current assets | |||||||||||||||
| total assets | |||||||||||||||
| Bank overdraft | |||||||||||||||
| Bank loan | |||||||||||||||
| Trade Creditors | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| other short term finances | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| other current liabilities | |||||||||||||||
| total current liabilities | |||||||||||||||
| loans | |||||||||||||||
| hp & lease commitments | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| other liabilities | |||||||||||||||
| provisions | |||||||||||||||
| total long term liabilities | |||||||||||||||
| total liabilities | |||||||||||||||
| net assets | |||||||||||||||
| total shareholders funds |
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | |||||||||||||||
| Amortisation | |||||||||||||||
| Tax | |||||||||||||||
| Stock | |||||||||||||||
| Debtors | |||||||||||||||
| Creditors | |||||||||||||||
| Accruals and Deferred Income | |||||||||||||||
| Deferred Taxes & Provisions | |||||||||||||||
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | |||||||||||||||
| Change in Investments | |||||||||||||||
| cash flow from investments | |||||||||||||||
| Financing Activities | |||||||||||||||
| Bank loans | |||||||||||||||
| Group/Directors Accounts | |||||||||||||||
| Other Short Term Loans | |||||||||||||||
| Long term loans | |||||||||||||||
| Hire Purchase and Lease Commitments | |||||||||||||||
| other long term liabilities | |||||||||||||||
| share issue | |||||||||||||||
| interest | |||||||||||||||
| cash flow from financing | |||||||||||||||
| cash and cash equivalents | |||||||||||||||
| cash | |||||||||||||||
| overdraft | |||||||||||||||
| change in cash |
the paul bevan cancer foundation Credit Report and Business Information
The Paul Bevan Cancer Foundation Competitor Analysis
Perform a competitor analysis for the paul bevan cancer foundation by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mature companies, companies in SL6 area or any other competitors across 12 key performance metrics.
the paul bevan cancer foundation Ownership
THE PAUL BEVAN CANCER FOUNDATION group structure
The Paul Bevan Cancer Foundation has no subsidiary companies.
Ultimate parent company
THE PAUL BEVAN CANCER FOUNDATION
02807079
the paul bevan cancer foundation directors
The Paul Bevan Cancer Foundation currently has 3 directors. The longest serving directors include Mr Christopher Aitken (Feb 2023) and Ms Janet King (Sep 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Christopher Aitken | England | 74 years | Feb 2023 | - | Director |
| Ms Janet King | England | 64 years | Sep 2024 | - | Director |
| Mr Jonathan Toohey | England | 60 years | Sep 2024 | - | Director |
P&L
March 2024turnover
0
0%
operating profit
0
0%
gross margin
0%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2024net assets
0
0%
total assets
0
0%
cash
0
0%
net assets
Total assets minus all liabilities
the paul bevan cancer foundation company details
company number
02807079
Type
Private Limited by guarantee without Share Capital Exempt from using Limited
industry
86900 - Other human health activities
incorporation date
April 1993
age
32
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
March 2024
previous names
N/A
accountant
-
auditor
-
address
thames hospice windsor road, maidenhead, SL6 2DN
Bank
-
Legal Advisor
-
the paul bevan cancer foundation Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to the paul bevan cancer foundation.
the paul bevan cancer foundation Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for THE PAUL BEVAN CANCER FOUNDATION. This can take several minutes, an email will notify you when this has completed.
the paul bevan cancer foundation Companies House Filings - See Documents
| date | description | view/download |
|---|
